Literature DB >> 9169761

Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity.

T Tsuboi1, Y M Cao, Y Hitsumoto, T Yanagi, H Kanbara, M Torii.   

Abstract

We have developed transmission-blocking monoclonal antibodies (MAbs) against Plasmodium yoelii 21-kDa (Pys21) and 28-kDa (Pys25) ookinete surface proteins. These MAbs block infectivity of P. yoelii to Anopheles stephensi. One MAb, 14, cross-reacted by Western blotting with a 28-kDa surface protein (Pbs25) of P. berghei ookinetes and blocked oocyst development, as assayed by direct mosquito feeds on passively immunized P. berghei-infected mice. In total, we have identified two ookinete surface proteins in P. yoelii, one of which is also present in P. berghei. The transmission-blocking activity of the anti-Pys25 MAb 4 was complete and more potent than that of the anti-Pys21 MAb 2. Moreover, Fab fragments of MAb 4 had transmission-blocking activity in mice. In comparison, Fab fragments of MAb 2 did not have detectable transmission-blocking effect, although F(ab')2 did. Furthermore, MAb 2 and MAb 4 appeared to block the in vitro formation and development of zygotes as well.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169761      PMCID: PMC175313          DOI: 10.1128/iai.65.6.2260-2264.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Immunity to sexual stages of malaria parasites.

Authors:  R Carter; N Kumar; I Quakyi; M Good; K Mendis; P Graves; L Miller
Journal:  Prog Allergy       Date:  1988

2.  Comparison of the primary structure of the 25 kDa ookinete surface antigens of Plasmodium falciparum and Plasmodium gallinaceum reveal six conserved regions.

Authors:  D C Kaslow; C Syin; T F McCutchan; L H Miller
Journal:  Mol Biochem Parasitol       Date:  1989-03-15       Impact factor: 1.759

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Preparation of Fab fragments from IgGs of different animal species.

Authors:  M G Mage
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Murine complement reduces infectivity of Plasmodium yoelii to mosquitoes.

Authors:  T Tsuboi; Y M Cao; M Torii; Y Hitsumoto; H Kanbara
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies.

Authors:  C A Grotendorst; N Kumar; R Carter; D C Kaushal
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.

Authors:  D C Kaslow; I A Quakyi; C Syin; M G Raum; D B Keister; J E Coligan; T F McCutchan; L H Miller
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

9.  Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing.

Authors:  D Read; A H Lensen; S Begarnie; S Haley; A Raza; R Carter
Journal:  Parasite Immunol       Date:  1994-10       Impact factor: 2.280

10.  Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito.

Authors:  A N Vermeulen; T Ponnudurai; P J Beckers; J P Verhave; M A Smits; J H Meuwissen
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more
  21 in total

1.  P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions.

Authors:  A M Tomas; G Margos; G Dimopoulos; L H van Lin; T F de Koning-Ward; R Sinha; P Lupetti; A L Beetsma; M C Rodriguez; M Karras; A Hager; J Mendoza; G A Butcher; F Kafatos; C J Janse; A P Waters; R E Sinden
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  Blocking effect of a monoclonal antibody against recombinant Pvs25 on sporozoite development in Anopheles sinensis.

Authors:  Sung-Ung Moon; Hyung-Hwan Kim; Tong-Soo Kim; Kyung-Mi Choi; Chang-Mi Oh; Yong-Joo Ahn; Seo-Kyoung Hwang; Youngjoo Sohn; E-Hyun Shin; Hyuck Kim; Hyeong-Woo Lee
Journal:  Clin Vaccine Immunol       Date:  2010-06-16

3.  Monoclonal antibody against the Plasmodium falciparum chitinase, PfCHT1, recognizes a malaria transmission-blocking epitope in Plasmodium gallinaceum ookinetes unrelated to the chitinase PgCHT1.

Authors:  Rebecca C Langer; Fengwu Li; Vsevolod Popov; Alexander Kurosky; Joseph M Vinetz
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

4.  Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes.

Authors:  H Hisaeda; A W Stowers; T Tsuboi; W E Collins; J S Sattabongkot; N Suwanabun; M Torii; D C Kaslow
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

Authors:  T Tsuboi; D C Kaslow; M M Gozar; M Tachibana; Y M Cao; M Torii
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

6.  A very large C-loop in EGF domain IV is characteristic of the P28 family of ookinete surface proteins.

Authors:  Babita Sharma; Rahul Dev Ambedkar; Ajay K Saxena
Journal:  J Mol Model       Date:  2008-12-05       Impact factor: 1.810

7.  Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection.

Authors:  Takeshi Arakawa; Mayumi Tachibana; Takeshi Miyata; Tetsuya Harakuni; Hideyasu Kohama; Yasunobu Matsumoto; Naotoshi Tsuji; Hajime Hisaeda; Anthony Stowers; Motomi Torii; Takafumi Tsuboi
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

8.  High mobility group protein HMGB2 is a critical regulator of plasmodium oocyst development.

Authors:  Mathieu Gissot; Li-Min Ting; Thomas M Daly; Lawrence W Bergman; Photini Sinnis; Kami Kim
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

9.  Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.

Authors:  Godfree Mlambo; Jorge Maciel; Nirbhay Kumar
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

10.  EGF domain II of protein Pb28 from Plasmodium berghei interacts with monoclonal transmission blocking antibody 13.1.

Authors:  Babita Sharma; Manoj Kumar Jaiswal; Ajay K Saxena
Journal:  J Mol Model       Date:  2008-12-09       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.